Direct to consumer advertising in pharmaceutical markets

Journal of Health Economics

Volumn 25, Issue 1, 2006, Pages 102-130

  Brekke, Kurt R ^a   Kuhn, Michael ^b  

^a NORWEGIAN SCHOOL OF ECONOMICS   (Norway)

^b UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Marketing; Oligopoly; Pharmaceuticals

Indexed keywords

ADVERTISING; MARKET CONDITIONS;

ADVERTIZING; ARTICLE; COMPARATIVE STUDY; CONSUMER; COST BENEFIT ANALYSIS; DRUG INDUSTRY; DRUG INFORMATION; DRUG SENSITIVITY; MARKETING; MATHEMATICAL ANALYSIS; PHYSICIAN; PRESCRIPTION;

ADVERTISING; CONSUMER PARTICIPATION; DRUG COSTS; DRUG INDUSTRY; EUROPEAN UNION; MODELS, ECONOMETRIC; PILOT PROJECTS;

EID: 29244465089     PISSN: 01676296     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhealeco.2005.06.003     Document Type: Article

References (30)

1. P. Azoulay Do pharmaceutical sales respond to scientific evidence? Journal of Economics and Management Strategy 11 4 2002 551 594
2. E.R. Berndt, L. Bui, D. Reiley, and G. Urban Information, marketing, and pricing in the U.S. antiulcer drug market American Economic Review, Papers and Proceedings 85 1995 100 105
3. E.R. Berndt, L. Bui, D. Reiley, and G. Urban The roles of marketing, product quality and price competition in the growth and composition of the U.S. anti-ulcer drug industry T.F. Bresnahan R.J. Gordon The Economics of New Goods. Studies in Income and Wealth, vol. 58 1997 University of Chicago Press Chicago 277 322
4. G. Butters Equilibrium distributions of sale and advertising prices Review of Economic Studies 44 3 1977 465 491
5. A. Cabrales Pharmaceutical Generics, Vertical Product Differentiation and Public Policy 2004 Universitat Pompeu Fabra Mimeo
6. J.E. Calfee, C. Winston, and R. Stempski Direct-to-consumer advertising and the demand for cholesterol-reducing drugs Journal of Law and Economics XLV 2002 673 689
7. R. Dorfman, and P.O. Steiner Optimal advertising and optimal quality American Economic Review 44 5 1954 826 836
8. E.W. Eckard Jr. Competition and the cigarette TV advertising ban Economic Inquiry 29 1 1991 119 133
9. D. Fudenberg, and J. Tirole The fat-cat effect, the puppy-dog ploy, and the lean and hungry look American Economic Review, Papers and Proceedings 74 1984 361 366
10. H.G. Grabowski, and J. Vernon Brand loyalty, entry, and price competition in pharmaceuticals after the 1984 Drug Act Journal of Law and Economics 35 1992 331 350
11. G. Grossman, and C. Shapiro Informative advertising with differentiated products Review of Economic Studies 51 1984 63 81
12. M.A. Hurwitz, and R.E. Caves Persuasion or information? Promotion and shares of brand name and generic pharmaceuticals Journal of Law and Economics 31 1988 299 320
13. T. Iizuka What explains the use of direct-to-consumer advertising of prescription drugs? Journal of Industrial Economics LII 3 2004 349 379
14. T. Iizuka, and G.Z. Jin The effects of prescription drug advertising on doctor visits. Journal of Economics & Management Strategy 14 3 2005 701 727
15. Konrad, K., 2002. Competition for prescription drugs. Mimeo, Wissenschaftszentrum Berlin.
16. I. Königbauer Advertising and generic market entry 2004 University of Munich Mimeo
17. K.B. Leffler Persuasion or information? The economics of prescription drug advertising Journal of Law and Economics 24 1 1981 45 74
18. D.C. Ling, E.R. Berndt, and M.K. Kyle Deregulating direct-to-consumer marketing of prescription drugs: effects on prescription and over-the-counter product sales Journal of Law and Economics XLV 2002 691 723
19. J.L. Lu, and W.S. Comanor Strategic pricing of new pharmaceuticals Review of Economics and Statistics 80 1998 108 118
20. D. Lundin Moral Hazard in physician prescription behavior Journal of Health Economics 19 2000 639 662
21. E. Mossialos Regulating Expenditure on Medicines in European Union Countries R.B. Saltman J. Figueras C. Sakellarides Critical Challenges for Health Care Reform in Europe 1998 Open University Press Buckingham and Philadelphia (Chapter 11)
22. J.A. Rizzo Advertising and competition in the ethical pharmaceutical industry: The case of antihypertensive drugs Journal of Law and Economics 42 1 1999 89 116
23. M.B. Rosenthal, E.R. Berndt, J.M. Donohue, R.G. Frank, and A.M. Epstein Promotion of prescription drugs to consumers New England Journal of Medicine 346 7 2002 498 504
24. P.H. Rubin, and J.L. Schrag Mitigating agency problems by advertising, with special reference to managed health care Southern Economic Journal 66 1 1999 39 60
25. F.M. Scherer, and D. Ross Industrial Market Structure and Economic Performance 1990 Houghton Mifflin Company Boston (Chapter 16)
26. F.M. Scherer The pharmaceutical industry A.J. Cuyler J.P. Newhouse Handbook of Health Economics 2000 Elsevier North Holland, Amsterdam (Chapter 25)
27. S.O. Schweitzer Pharmaceutical Economics and Policy 1997 Oxford University Press New York
28. F.M. Scott Morton Barriers to entry, brand advertising, and generic entry in the US pharmaceutical industry International Journal of Industrial Organization 18 2000 1085 1104
29. M.S. Wilkes, R.A. Bell, and R.L. Kravitz Direct-to-consumer prescription drug advertising: trends, impact and implications Health Affairs (Millwood) 19 2 2000 110 128
30. P. Zweifel, and F. Breyer Health Economics 1997 Oxford University Press New York